Invesco’s Anavex Life Sciences AVXL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.97M | Buy |
863,959
+309,605
| +56% | +$2.85M | ﹤0.01% | 1928 |
|
2025
Q1 | $4.76M | Sell |
554,354
-60,694
| -10% | -$521K | ﹤0.01% | 2176 |
|
2024
Q4 | $6.61M | Buy |
615,048
+590,639
| +2,420% | +$6.34M | ﹤0.01% | 2097 |
|
2024
Q3 | $139K | Sell |
24,409
-875
| -3% | -$4.97K | ﹤0.01% | 3559 |
|
2024
Q2 | $107K | Sell |
25,284
-2,956
| -10% | -$12.5K | ﹤0.01% | 3729 |
|
2024
Q1 | $144K | Buy |
28,240
+306
| +1% | +$1.56K | ﹤0.01% | 3688 |
|
2023
Q4 | $260K | Sell |
27,934
-23,323
| -46% | -$217K | ﹤0.01% | 3468 |
|
2023
Q3 | $336K | Buy |
51,257
+19,603
| +62% | +$128K | ﹤0.01% | 3382 |
|
2023
Q2 | $257K | Sell |
31,654
-239
| -0.7% | -$1.94K | ﹤0.01% | 3532 |
|
2023
Q1 | $273K | Buy |
31,893
+1,601
| +5% | +$13.7K | ﹤0.01% | 3513 |
|
2022
Q4 | $281K | Sell |
30,292
-2,899
| -9% | -$26.8K | ﹤0.01% | 3515 |
|
2022
Q3 | $342K | Buy |
33,191
+3,514
| +12% | +$36.2K | ﹤0.01% | 3433 |
|
2022
Q2 | $297K | Sell |
29,677
-671
| -2% | -$6.72K | ﹤0.01% | 3561 |
|
2022
Q1 | $374K | Sell |
30,348
-404,891
| -93% | -$4.99M | ﹤0.01% | 3504 |
|
2021
Q4 | $7.55M | Buy |
435,239
+398,718
| +1,092% | +$6.91M | ﹤0.01% | 2172 |
|
2021
Q3 | $655K | Sell |
36,521
-561,977
| -94% | -$10.1M | ﹤0.01% | 3275 |
|
2021
Q2 | $13.7M | Sell |
598,498
-526,867
| -47% | -$12M | ﹤0.01% | 1858 |
|
2021
Q1 | $16.8M | Buy |
1,125,365
+900,652
| +401% | +$13.5M | ﹤0.01% | 1656 |
|
2020
Q4 | $1.21M | Buy |
+224,713
| New | +$1.21M | ﹤0.01% | 2850 |
|
2020
Q3 | – | Sell |
-133,005
| Closed | -$654K | – | 3586 |
|
2020
Q2 | $654K | Buy |
+133,005
| New | +$654K | ﹤0.01% | 2996 |
|